VIÊM PHỔI LIÊN QUAN ĐẾN CÚM Ở TRẺ EM ĐIỀU TRỊ TẠI BỆNH VIỆN ĐA KHOA XANH PÔN

Abstract

Objective: To describe the clinical and paraclinical characteristics and assess certain factors related to the severity of pneumonia associated with influenza in children. Study Design: A descriptive case series study, involving patients aged 0-16 years with pneumonia and a positive diagnosis for influenza, treated at Xanh Pon General Hospital from January 2022 to May 2024. Key variables such as epidemiology, clinical, paraclinical characteristics, severity, time to start antiviral treatment, and treatment outcomes were analyzed. Results: A total of 130 children under 16 years old with influenza-related pneumonia were included in the study. Results showed that children under 5 years of age, particularly those under 24 months, had a higher risk of contracting the disease. The incidence was higher in males than females (62.31% compared to 37.69%). The influenza vaccination rate was low (26.92%). The most common symptoms were fever, cough, runny nose and crackles in the lungs. The most prevalent X-ray finding was scattered pneumonia (68.46%). Most patients had a treatment duration of less than 14 days, with a high recovery rate. Children under 24 months of age and those who received antiviral drugs late (after 48 hours) had a higher risk of developing severe pneumonia (p < 0.05). Conclusion: Children under 5 years old are at high risk of influenza-related pneumonia, especially those under 24 months who are at risk of severe pneumonia. The rate of children vaccinated against the influenza is still low. Early use of antiviral medication (within 48 hours) is an important factor in reducing the severity of the disease.